{"transactions":[{"id":824920,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:44:35.000Z","date":"2026-03-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":3924,"price":0.65,"value":2550.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2026."}],"balance_after":882811,"source":{"system":"sec-edgar","filing":"0001437749-26-010709","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926010709/rdgdoc.xml","form_type":"4"}},{"id":827900,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-26T20:51:46.000Z","date":"2026-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":36418,"price":0.694,"value":25274.092,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 24, 2026."}],"balance_after":886735,"source":{"system":"sec-edgar","filing":"0001437749-26-009966","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926009966/rdgdoc.xml","form_type":"4"}},{"id":833009,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-20T19:14:23.000Z","date":"2026-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":8072,"price":0.6346,"value":5122.4912,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2026."}],"balance_after":923153,"source":{"system":"sec-edgar","filing":"0001437749-26-009205","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926009205/rdgdoc.xml","form_type":"4"}},{"id":836279,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-18T23:42:42.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":410000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 16, 2027, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 16, 2030."}],"balance_after":410000,"derivative":{"exercise_price":0.6795,"expiration_date":"2036-03-16","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0001437749-26-008909","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926008909/rdgdoc.xml","form_type":"4"}},{"id":836278,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-18T23:42:42.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 16, 2026, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date."}],"balance_after":931225,"source":{"system":"sec-edgar","filing":"0001437749-26-008909","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926008909/rdgdoc.xml","form_type":"4"}},{"id":918671,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:53:18.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9265,"price":0.6085,"value":5637.7525,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2026."}],"balance_after":731225,"source":{"system":"sec-edgar","filing":"0001437749-26-003253","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774926003253/rdgdoc.xml","form_type":"4"}},{"id":1187503,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-04-01T20:53:58.000Z","date":"2025-03-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":3913,"price":0.4212,"value":1648.1556,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2025."}],"balance_after":740490,"source":{"system":"sec-edgar","filing":"0001437749-25-010486","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925010486/rdgdoc.xml","form_type":"4"}},{"id":1191796,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-27T01:53:56.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":610000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029."}],"balance_after":610000,"derivative":{"exercise_price":0.5126,"expiration_date":"2035-03-24","underlying":"Common Stock","underlying_shares":610000},"source":{"system":"sec-edgar","filing":"0001437749-25-009451","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925009451/rdgdoc.xml","form_type":"4"}},{"id":1191795,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-27T01:53:56.000Z","date":"2025-03-24","kind":"grant","planned":false,"acquired":true,"shares":406000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date."}],"balance_after":744403,"source":{"system":"sec-edgar","filing":"0001437749-25-009451","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925009451/rdgdoc.xml","form_type":"4"}},{"id":1196496,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-21T01:27:49.000Z","date":"2025-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":8050,"price":0.5702,"value":4590.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025."}],"balance_after":338403,"source":{"system":"sec-edgar","filing":"0001437749-25-008650","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925008650/rdgdoc.xml","form_type":"4"}},{"id":1286738,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-05T01:11:32.000Z","date":"2025-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9242,"price":0.6798,"value":6282.7116,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2025."}],"balance_after":346453,"source":{"system":"sec-edgar","filing":"0001437749-25-002803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774925002803/rdgdoc.xml","form_type":"4"}},{"id":1557272,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-04-01T23:16:57.000Z","date":"2024-03-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":3902,"price":1.3,"value":5072.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on March 28, 2024."}],"balance_after":355695,"source":{"system":"sec-edgar","filing":"0001437749-24-010475","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924010475/rdgdoc.xml","form_type":"4"}},{"id":1566718,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-21T00:12:04.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":410000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 18, 2025, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 18, 2028."}],"balance_after":410000,"derivative":{"exercise_price":1.16,"expiration_date":"2034-03-17","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0001437749-24-008753","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924008753/rdgdoc.xml","form_type":"4"}},{"id":1566717,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-21T00:12:04.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date."}],"balance_after":420122,"source":{"system":"sec-edgar","filing":"0001437749-24-008753","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924008753/rdgdoc.xml","form_type":"4"}},{"id":1566716,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-21T00:12:04.000Z","date":"2024-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9220,"price":1.2,"value":11064.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to administrative oversight."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2024."}],"balance_after":330122,"source":{"system":"sec-edgar","filing":"0001437749-24-008753","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924008753/rdgdoc.xml","form_type":"4"}},{"id":1566715,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-21T00:12:04.000Z","date":"2023-12-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":34288,"price":0.71,"value":24344.48,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to administrative oversight."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023."}],"balance_after":339342,"source":{"system":"sec-edgar","filing":"0001437749-24-008753","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924008753/rdgdoc.xml","form_type":"4"}},{"id":1566714,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-21T00:12:04.000Z","date":"2023-03-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":3683,"price":0.75,"value":2762.25,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This transaction is being reported late due to administrative oversight."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2023."}],"balance_after":373630,"source":{"system":"sec-edgar","filing":"0001437749-24-008753","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774924008753/rdgdoc.xml","form_type":"4"}},{"id":1943986,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-21T23:54:12.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":410000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on February 2, 2024, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on February 2, 2027."}],"balance_after":410000,"derivative":{"exercise_price":0.78,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":410000},"source":{"system":"sec-edgar","filing":"0001437749-23-007440","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923007440/rdgdoc.xml","form_type":"4"}},{"id":1943985,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-21T23:54:12.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":205000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall fully vest on December 8, 2023."}],"balance_after":205000,"derivative":{"exercise_price":0.78,"expiration_date":"2033-03-16","underlying":"Common Stock","underlying_shares":205000},"source":{"system":"sec-edgar","filing":"0001437749-23-007440","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923007440/rdgdoc.xml","form_type":"4"}},{"id":1943984,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:54:12.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of February 2, 2023, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date."}],"balance_after":316788,"source":{"system":"sec-edgar","filing":"0001437749-23-007440","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923007440/rdgdoc.xml","form_type":"4"}},{"id":1943983,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:54:12.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":54157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023."}],"balance_after":226788,"source":{"system":"sec-edgar","filing":"0001437749-23-007440","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923007440/rdgdoc.xml","form_type":"4"}},{"id":1943982,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-21T23:54:12.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023."}],"balance_after":172631,"source":{"system":"sec-edgar","filing":"0001437749-23-007440","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774923007440/rdgdoc.xml","form_type":"4"}},{"id":2291521,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-25T20:40:20.000Z","date":"2022-04-22","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over a four-year period, with 25% of the shares subject to the stock option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares in 36 equal monthly installments thereafter."}],"balance_after":84061,"derivative":{"exercise_price":0.77,"expiration_date":"2029-05-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001437749-22-009651","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922009651/rdgdoc.xml","form_type":"4"}},{"id":2291520,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-25T20:40:20.000Z","date":"2022-04-22","kind":"exercise","acquired":true,"shares":40000,"price":0.77,"value":30800.0,"ownership":{"direct":true},"balance_after":127631,"source":{"system":"sec-edgar","filing":"0001437749-22-009651","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922009651/rdgdoc.xml","form_type":"4"}},{"id":2314709,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-31T01:19:42.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":262500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 28, 2023, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 28, 2026."}],"balance_after":262500,"derivative":{"exercise_price":5.09,"expiration_date":"2032-03-27","underlying":"Common Stock","underlying_shares":262500},"source":{"system":"sec-edgar","filing":"0001437749-22-007738","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922007738/rdgdoc.xml","form_type":"4"}},{"id":2314708,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-31T01:19:42.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the fourth anniversary of the grant date."}],"balance_after":87631,"source":{"system":"sec-edgar","filing":"0001437749-22-007738","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922007738/rdgdoc.xml","form_type":"4"}},{"id":2607886,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-11T22:53:33.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":5828,"price":10.2,"value":59445.6,"ownership":{"direct":false,"nature":"By joint tenancy with Frances Chang and Sean Tucker"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021."}],"balance_after":51465,"source":{"system":"sec-edgar","filing":"0001437749-21-019515","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774921019515/rdgdoc.xml","form_type":"4"}},{"id":2607885,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-11T22:53:33.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":4172,"price":10.2,"value":42554.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021."}],"balance_after":43881,"source":{"system":"sec-edgar","filing":"0001437749-21-019515","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774921019515/rdgdoc.xml","form_type":"4"}},{"id":2665300,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:23:18.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the board of directors of Vaxart, Inc. on March 25, 2021, subject to stockholder approval of an amendment to the Vaxart, Inc. 2019 Equity Incentive Plan, under which the stock option was granted. Vaxart, Inc.'s stockholders approved the plan amendment on June 16, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 25, 2022, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 25, 2025."}],"balance_after":100000,"derivative":{"exercise_price":6.27,"expiration_date":"2031-03-24","underlying":"Common stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001437749-21-015074","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774921015074/rdgdoc.xml","form_type":"4"}},{"id":2780582,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-19T21:04:34.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":1006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested"}],"balance_after":0,"derivative":{"exercise_price":6.49,"expiration_date":"2021-03-29","underlying":"Common stock","underlying_shares":1006},"source":{"system":"sec-edgar","filing":"0001437749-21-006473","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774921006473/rdgdoc.xml","form_type":"4"}},{"id":2780581,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-19T21:04:34.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":1006,"price":6.49,"value":6528.94,"ownership":{"direct":true},"balance_after":48053,"source":{"system":"sec-edgar","filing":"0001437749-21-006473","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774921006473/rdgdoc.xml","form_type":"4"}},{"id":3058166,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-14T20:21:30.000Z","date":"2020-08-13","kind":"exercise","acquired":false,"shares":4026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.49,"expiration_date":"2020-08-26","underlying":"Common Stock","underlying_shares":4026},"source":{"system":"sec-edgar","filing":"0001437749-20-018044","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774920018044/rdgdoc.xml","form_type":"4"}},{"id":3058165,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-08-14T20:21:30.000Z","date":"2020-08-13","kind":"exercise","acquired":true,"shares":4026,"price":6.49,"value":26128.74,"ownership":{"direct":true},"balance_after":51679,"source":{"system":"sec-edgar","filing":"0001437749-20-018044","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774920018044/rdgdoc.xml","form_type":"4"}},{"id":3117939,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-06-09T20:38:54.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the board of directors of Vaxart, Inc. on March 24, 2020, subject to stockholder approval of an amendment to the Vaxart, Inc. 2019 Equity Incentive Plan, under which the stock option was granted. Vaxart, Inc.'s stockholders approved the plan amendment on June 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on the date of grant, and thereafter in 24 equal monthly installments commencing on the first day of the calendar month following the grant date such that the stock option shall be fully vested on April 1, 2022."}],"balance_after":360000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-03-23","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001437749-20-012741","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774920012741/rdgdoc.xml","form_type":"4"}},{"id":3528957,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-14T21:28:11.000Z","date":"2019-05-12","kind":"grant","acquired":true,"shares":124061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date of May 10, 2019, and the remaining shares subject to the option vesting in equal monthly installments over the next 36 months."}],"balance_after":124061,"derivative":{"exercise_price":0.77,"expiration_date":"2029-05-11","underlying":"Common Stock","underlying_shares":124061},"source":{"system":"sec-edgar","filing":"0001209191-19-029721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919119029721/doc4.xml","form_type":"4"}},{"id":3557241,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2019-04-12T22:04:57.000Z","date":"2019-04-11","kind":"purchase","acquired":true,"shares":27273,"price":1.1,"value":30000.3,"ownership":{"direct":false,"nature":"By joint tenancy with Frances Chang and Sean Tucker"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a common warrant to purchase one share of the Issuer's common stock at the combined purchase price of $1.10.  The Reporting person may not exercise any portion of the common warrant to the extent that he would beneficially own more than 4.99% of the outstanding common stock immediately after exercise, except that upon at least 61 days' prior notice from the Reporting Person to the Issuer, he may increase the amount of beneficial ownership of outstanding stock after exercising his common warrants up to 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the common warrants."}],"balance_after":27273,"derivative":{"exercise_price":1.1,"exercise_date":"2019-04-11","expiration_date":"2024-04-11","underlying":"Common Stock","underlying_shares":27273},"source":{"system":"sec-edgar","filing":"0001437749-19-007119","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774919007119/rdgdoc.xml","form_type":"4"}},{"id":3557240,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2019-04-12T22:04:57.000Z","date":"2019-04-11","kind":"purchase","acquired":true,"shares":27273,"price":1.1,"value":30000.3,"ownership":{"direct":false,"nature":"By joint tenancy with Frances Chang and Sean Tucker"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with a common warrant to purchase one share of the Issuer's common stock at the combined purchase price of $1.10.  The Reporting person may not exercise any portion of the common warrant to the extent that he would beneficially own more than 4.99% of the outstanding common stock immediately after exercise, except that upon at least 61 days' prior notice from the Reporting Person to the Issuer, he may increase the amount of beneficial ownership of outstanding stock after exercising his common warrants up to 9.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the common warrants."}],"balance_after":52661,"source":{"system":"sec-edgar","filing":"0001437749-19-007119","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000143774919007119/rdgdoc.xml","form_type":"4"}},{"id":3916545,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-05-30T01:41:48.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this Option shall vest as follows:  1/4th of the total number of shares subject to the Option shall vest on the day preceding the 12-month anniversary of the vesting commencement date of February 13, 2018 and 1/48th of the total number of shares subject to the Option shall vest on the day preceding each monthly anniversary of the vesting commencement date thereafter."}],"balance_after":14000,"derivative":{"exercise_price":5.17,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-18-034055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118034055/doc4.xml","form_type":"4"}},{"id":3997402,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-15T01:11:37.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":2013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":6.49,"expiration_date":"2018-03-13","underlying":"Common Stock","underlying_shares":2013},"source":{"system":"sec-edgar","filing":"0001209191-18-019742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118019742/doc4.xml","form_type":"4"}},{"id":3997401,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-03-15T01:11:37.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":2013,"price":6.49,"value":13064.37,"ownership":{"direct":true},"balance_after":47653,"source":{"system":"sec-edgar","filing":"0001209191-18-019742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118019742/doc4.xml","form_type":"4"}},{"id":4056711,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Optin (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":9060,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"On June 24, 2017, Reporting Person was granted an option to purchase 450,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.08  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 9,060 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $4.07 (as adjusted for the Stock Split). The option vests with respect to 25% of the underlying shares on the first anniversary of the vesting commencement date of June 14, 2017 and with respect to the remaining shares underlying the option in 36 equal monthly installments thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On June 24, 2017, Reporting Person was granted an option to purchase 450,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.08  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 9,060 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $4.07 (as adjusted for the Stock Split). The option vests with respect to 25% of the underlying shares on the first anniversary of the vesting commencement date of June 14, 2017 and with respect to the remaining shares underlying the option in 36 equal monthly installments thereafter."}],"balance_after":9060,"derivative":{"exercise_price":4.07,"expiration_date":"2027-06-24","underlying":"Common Stock","underlying_shares":9060},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056710,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Optin (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":7731,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"On March 25, 2016, Reporting Person was granted an option to purchase 384,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.26  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 7,731 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $12.98 (as adjusted for the Stock Split). The option vests in 48 equal monthly installments beginning from March 25, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 25, 2016, Reporting Person was granted an option to purchase 384,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.26  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 7,731 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $12.98 (as adjusted for the Stock Split). The option vests in 48 equal monthly installments beginning from March 25, 2016."}],"balance_after":7731,"derivative":{"exercise_price":12.98,"expiration_date":"2026-03-25","underlying":"Common Stock","underlying_shares":7731},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056709,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":10067,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"On July 23, 2015, Reporting Person was granted an option to purchase 500,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.35  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 10,067 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $17.49 (as adjusted for the Stock Split). The option vests in 48 equal monthly installments beginning from July 1, 2015."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On July 23, 2015, Reporting Person was granted an option to purchase 500,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.35  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 10,067 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $17.49 (as adjusted for the Stock Split). The option vests in 48 equal monthly installments beginning from July 1, 2015."}],"balance_after":10067,"derivative":{"exercise_price":17.49,"expiration_date":"2025-07-23","underlying":"Common Stock","underlying_shares":10067},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056708,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":11604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On May 8, 2014, Reporting Person was granted an option to purchase 576,338 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.16  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 11,604 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $8.03 (as adjusted for the Stock Split). This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On May 8, 2014, Reporting Person was granted an option to purchase 576,338 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.16  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 11,604 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $8.03 (as adjusted for the Stock Split). This option is fully vested."}],"balance_after":11604,"derivative":{"exercise_price":8.03,"expiration_date":"2024-05-08","underlying":"Common Stock","underlying_shares":11604},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056707,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":10523,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On August 8, 2013, Reporting Person was granted an option to purchase 522,676 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 10,523 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On August 8, 2013, Reporting Person was granted an option to purchase 522,676 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 10,523 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."}],"balance_after":10523,"derivative":{"exercise_price":6.49,"expiration_date":"2023-08-08","underlying":"Common Stock","underlying_shares":10523},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056706,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":3020,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On April 13, 2012, Reporting Person was granted an option to purchase 150,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.16  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 3,020 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $8.03 (as adjusted for the Stock Split). This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On April 13, 2012, Reporting Person was granted an option to purchase 150,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.16  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 3,020 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $8.03 (as adjusted for the Stock Split). This option is fully vested."}],"balance_after":3020,"derivative":{"exercise_price":8.03,"expiration_date":"2022-04-13","underlying":"Common Stock","underlying_shares":3020},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056705,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":1006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On March 30, 2011, Reporting Person was granted an option to purchase 50,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 1,006 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 30, 2011, Reporting Person was granted an option to purchase 50,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 1,006 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."}],"balance_after":1006,"derivative":{"exercise_price":6.49,"expiration_date":"2021-03-30","underlying":"Common Stock","underlying_shares":1006},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056704,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":4027,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On August 27, 2010, Reporting Person was granted an option to purchase 200,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 4,027 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 27, 2010, Reporting Person was granted an option to purchase 200,000 shares of the common stock of Old Vaxart under the Plan at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 4,027 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."}],"balance_after":4027,"derivative":{"exercise_price":6.49,"expiration_date":"2020-08-27","underlying":"Common Stock","underlying_shares":4027},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056703,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":2014,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On March 13, 2008, Reporting Person was granted an option to purchase 100,000 shares of the common stock of Old Vaxart under Old Vaxart's Amended and Restated 2007 Equity Incentive Plan (the \"Plan\") at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 2,014 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 13, 2008, Reporting Person was granted an option to purchase 100,000 shares of the common stock of Old Vaxart under Old Vaxart's Amended and Restated 2007 Equity Incentive Plan (the \"Plan\") at an exercise price of $0.13  per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 2,014 shares of the Issuer's common stock (as adjusted for the Stock Split) at a per share exercise price of $6.49 (as adjusted for the Stock Split). This option is fully vested."}],"balance_after":2014,"derivative":{"exercise_price":6.49,"expiration_date":"2018-03-13","underlying":"Common Stock","underlying_shares":2014},"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056702,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":25388,"ownership":{"direct":false,"nature":"By joint trust with Frances Chang and Sean Tucker"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."}],"balance_after":25388,"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056701,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":9060,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."}],"balance_after":9060,"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}},{"id":4056700,"issuer":{"id":6654,"kind":"organization","name":"Vaxart, Inc."},"owners":[{"id":55235,"kind":"person","name":"Tucker Sean","position":1,"cik":"0001652204","reported_name":"Tucker Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-02-16T01:33:47.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":45640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock of the corporation then known as Vaxart Biosciences, Inc. (\"Old Vaxart\") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of October 27, 2017, by and among the Issuer, Agora Merger Sub, Inc. and Old Vaxart (the \"Merger Agreement\"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into approximately 0.221 shares of the Issuer's common stock.   Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every 11 shares of common stock outstanding (the \"Stock Split\")."}],"balance_after":45640,"source":{"system":"sec-edgar","filing":"0001209191-18-010567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/72444/000120919118010567/doc4.xml","form_type":"4"}}]}